Linden Thomas Advisory Services’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Linden Thomas Advisory Services's RMD Position: Q3 2026 in Review
Linden Thomas Advisory Services increased its ResMed (RMD) stake by 1.2% in Q3 2026, buying an estimated $84.9K and bringing the position to 34,056 shares worth $7.53M. The position accounts for 0.6% of the portfolio, ranked #25.
Linden Thomas Advisory Services first reported a position in RMD in Q4 2022 and has held it in 16 quarters since. The position peaked at $9.07M in Q3 2025. 186 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Linden Thomas Advisory Services held 34,056 shares of ResMed worth $7.53M as of Q3 2026.
- Linden Thomas Advisory Services bought 389 ResMed shares in Q3 2026, an estimated $84.9K.
- ResMed made up 0.6% of Linden Thomas Advisory Services's portfolio in Q3 2026, its #25 holding.
- Linden Thomas Advisory Services first reported a position in ResMed in Q4 2022 and has held it in 16 quarters since.
- Linden Thomas Advisory Services's ResMed position peaked at $9.07M in Q3 2025.
- 186 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Linden Thomas Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.